Biotech

All Articles

3 biotechs attempt to trump the summer season warmth through dropping team

.As biotechs try to switch a fresh webpage in August, at the very least three firms have actually lo...

venBio lifts $528M for 5th life sciences VC fund

.Veteran venture capital organization venBio has actually lifted yet another half a billion dollars ...

Otsuka pays for $800M for Jnana and its clinical-stage PKU drug

.Otsuka Drug has actually grabbed Boston-based Jnana Therapeutics for $800 million so the Eastern bi...

FibroGen lays off 75% people staff as possession fails 2 additional trials

.FibroGen is actually drastically reorganizing its own business, laying off 75% of its USA team and ...

Tracon relax weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has actually chosen to unwind procedures weeks after an injectable immune sy...

Ideaya bags option on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is betting $400 thousand in biobucks that a bispecific antibody-drug conjugate (...

Takeda takes $140M reduction on fallen short epilepsy drug, promotes FDA run

.We actually understand that Takeda is planning to discover a road to the FDA for epilepsy medicatio...

VBI Vaccinations declare personal bankruptcy, seeks property purchase

.Immunology biotech VBI Vaccines is veering precariously near to the moment of truth, with programs ...

Celldex anti-cKIT antibody decrease hives in another phase 2 research

.It's hard to muscular tissue in on a room as competitive as immunology, however Celldex Therapies f...

Boehringer provides to $1.3 B for checkpoint inhibitor biotech

.Boehringer Ingelheim is providing to $1.3 billion for Nerio Rehabs and also a preclinical invulnera...